Register Now for The Outlook on Active Nutrition

Heart Health

Latest News


While soy typically takes up cholesterol research in the legume family, researchers at Tulane University and Arizona State University devised a meta-analysis evaluating non-soy legume consumption and any effect those foods may have had blood lipids.

Novus Nutrition Brands LLC (St. Louis), a subsidiary of Novus International Inc., has agreed to lease a dedicated R&D lab space for its Stratum Nutrition and Arenus divisions.

Privately held specialty pharmaceuticals firm Omthera Pharmaceuticals (Bedminster, NJ) has announced the results of tests it performed comparing its Epanova omega-3 fatty acid drug for high triglycerides to leading omega-3 drug Lovaza. The company says results show that Epanova was significantly more bioavailable than Lovaza.

Vitamin K specialist Natto Pharma (Lysaker, Norway) announced on Wednesday that the company has successfully defended two EU patents for vitamin K1 and K2 in heart health. The first patent claims vitamin K's use for decalcification of blood vessels and the second claims its use in preventing age-related stiffening of arteries, the company reported.

MegaNatural Patented

Polyphenolics’ (Madera, CA) has patented its MegaNatural-BP grape seed extract, clinically shown to offer benefits to blood pressure and metabolic syndrome.

Neptune Technology and Bioressources Inc. (Neptune; Laval, QC), a supplier of krill oil for dietary supplements, has introduced Onemia, a medical food for the pharmaceutical market.

The European Food Safety Authority (EFSA; Parma, Italy) has issued positive opinions for the omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) for eye, brain, and heart health.